LONG-TERM SURVIVAL IN ACUTE MYELOID-LEUKEMIA - THE-EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) EXPERIENCE

被引：38

作者：

BENNETT, JM

ANDERSEN, JW

CASSILETH, PA

机构：

[1] UNIV ROCHESTER,MED CTR,ROCHESTER,NY 14642

[2] HARVARD UNIV,SCH PUBL HLTH,DANA FARBER CANC INST,DIV BIOSTAT & EPIDEMIOL,BOSTON,MA 02115

[3] UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104

[4] HOSP UNIV PENN,DEPT MED,PHILADELPHIA,PA 19104

来源：

LEUKEMIA RESEARCH | 1991年 / 15卷 / 04期

关键词：

PROMYELOCYTIC LEUKEMIA; CURABILITY OF LEUKEMIA;

D O I：

10.1016/0145-2126(91)90124-C

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A retrospective analysis of two ECOG adult AML trials conducted from 1976 to 1983 was carried out focusing on long term disease-free survival. This report summarizes the data on 545 patients with a minimum follow up of 7 1/2 years. The complete remission rate was 57% with an estimated cure rate of 12%. Of several prognostic variables examined only FAB type M3 (promyelocytic leukemia) was statistically significant (estimated cure rate of 33% vs 9% for other FAB subtypes).

引用

页码：223 / 227

页数：5

共 23 条

[11] INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA [J].